Scholars Central

EditorialPublished 30 Nov 2024

Psychedelic-Assisted Psychotherapy for Treatment-Resistant Disorders Mechanisms, Evidence, and Future Directions

Authors: Liang Zhou

Health Science Journal

Volume 18 · Issue 11 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Psychedelic-assisted psychotherapy (PAP) is gaining attention as a novel and promising treatment for a range of mental health disorders, particularly those resistant to conventional therapies. Disorders such as depression, anxiety, post-traumatic stress disorder (PTSD), and substance use disorders have shown limited response to traditional treatments, prompting the exploration of psychedelics like psilocybin, MDMA, and LSD as adjuncts to psychotherapy. This review examines the current state of research into psychedelic-assisted psychotherapy, its mechanisms of action, the clinical evidence supporting its efficacy for treatment-resistant disorders, and the challenges and future directions of this therapeutic approach. By facilitating profound therapeutic experiences, psychedelics may help patients access deep emotional insights, enhance neuroplasticity, and reframe trauma or ingrained mental patterns, offering new hope for those with chronic mental health conditions.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Health Science Journal.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalHealth Science Journal
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Liang Zhou”